Research
Adherence
Obesity is associated with delayed cancer diagnosis and reduced treatment efficacy due to screening biases, technical challenges, and altered drug metabolism.
If you are obese, be proactive about your cancer screening. Inform your provider about your weight so they can use appropriate equipment and techniques. Ensure you receive full doses of chemotherapy and radiation, as obesity can sometimes lead to undertreatment. Advocate for yourself to ensure you get the standard of care.
GoodSupportsHIGH confidence
Obese individuals may be less likely to participate in screening programs... obesity is associated with reduced likelihood of prostate cancer diagnosis in a screened population... obese cancer patients are undertreated with systemic therapies... obesity is associated with increased daily prostate shift, rendering external beam radiation treatment more technically challenging
Why this rating
Strong epidemiologic evidence for screening biases and technical challenges in treatment.
Source
Obesity and cancer: mechanistic insights from transdisciplinary studies
Emma H. Allott et al. · Endocrine Related Cancer · 2015
narrative_reviewCited 178×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →